# Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue.

> **NCT00208715** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 100 (—)

## Conditions studied

- Major Depression
- Mental Health

## Interventions

- **DRUG:** Provigil

## Key facts

- **NCT ID:** NCT00208715
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 100 (—)
- **Last updated:** 2013-11-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00208715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00208715, "Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00208715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*